1. Home
  2. EKSO vs NBY Comparison

EKSO vs NBY Comparison

Compare EKSO & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EKSO
  • NBY
  • Stock Information
  • Founded
  • EKSO 2005
  • NBY 2000
  • Country
  • EKSO United States
  • NBY United States
  • Employees
  • EKSO N/A
  • NBY N/A
  • Industry
  • EKSO Medical/Dental Instruments
  • NBY
  • Sector
  • EKSO Health Care
  • NBY
  • Exchange
  • EKSO Nasdaq
  • NBY Nasdaq
  • Market Cap
  • EKSO 7.7M
  • NBY 6.3M
  • IPO Year
  • EKSO N/A
  • NBY 2007
  • Fundamental
  • Price
  • EKSO $4.95
  • NBY $1.18
  • Analyst Decision
  • EKSO Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • EKSO 2
  • NBY 1
  • Target Price
  • EKSO $34.75
  • NBY $0.85
  • AVG Volume (30 Days)
  • EKSO 47.1K
  • NBY 466.6K
  • Earning Date
  • EKSO 10-28-2025
  • NBY 11-10-2025
  • Dividend Yield
  • EKSO N/A
  • NBY N/A
  • EPS Growth
  • EKSO N/A
  • NBY N/A
  • EPS
  • EKSO N/A
  • NBY 0.41
  • Revenue
  • EKSO $14,749,000.00
  • NBY $9,781,000.00
  • Revenue This Year
  • EKSO N/A
  • NBY $23.91
  • Revenue Next Year
  • EKSO $49.96
  • NBY $32.05
  • P/E Ratio
  • EKSO N/A
  • NBY $3.11
  • Revenue Growth
  • EKSO N/A
  • NBY 113.47
  • 52 Week Low
  • EKSO $2.73
  • NBY $0.46
  • 52 Week High
  • EKSO $15.45
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • EKSO 54.44
  • NBY 45.81
  • Support Level
  • EKSO $4.61
  • NBY $1.17
  • Resistance Level
  • EKSO $5.44
  • NBY $1.31
  • Average True Range (ATR)
  • EKSO 0.38
  • NBY 0.14
  • MACD
  • EKSO -0.03
  • NBY 0.02
  • Stochastic Oscillator
  • EKSO 59.49
  • NBY 49.43

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: